# High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

> **NCT00965289** · PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 42 (actual)

## Conditions studied

- B-Cell Lymphoma

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT00965289
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2003-05
- **Final completion:** 2009-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2009-08-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965289, "High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00965289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*